Find the companies that fit the science, stage and buying need.
Broad healthcare and biotech searches generate large volumes of irrelevant companies. Arcton qualifies the underlying modality, indication, development stage, device need, manufacturing context and regulatory path before identifying the people who own the workstream.
Make the scientific and operating context explicit.
Qualification dimensions
- Therapeutic area, modality and product type
- Clinical or commercialization stage
- Drug-device or combination-product need
- Manufacturing, quality and validation requirements
- Internal capability gaps
- Geographic, funding and company-size fit
Buying paths
R&D and product development; clinical and medical leadership; CMC, technical operations and manufacturing; quality and regulatory; device, human-factors or combination-product leadership; operating C-suite for small or virtual companies.
Life Sciences and MedTech market research
- Challenge
- Build a manufacturer-led medtech universe across multiple medical fields without mixing hospitals, clinics, distributors, consultancies or software-only businesses.
- Approach
- Qualified companies with first-party evidence and canonical-domain checks, reviewed the wider employee pool, selected a capped senior set and audited corporate-domain aliases.
- Verified output
- 40 companies
- Prioritized across 11 medical fields, with 146 exact senior leaders and 100 independently verified business emails. Catch-all and unresolved outcomes were isolated.
Questions life-sciences teams ask.
Can you separate manufacturers from service providers?
Yes. Company type and first-party evidence are explicit qualification dimensions, so hospitals, clinics, distributors and software-only organizations can be excluded.
Can a project focus on a modality or stage?
Yes. Modality, indication, clinical or commercialization stage and manufacturing context can define the target universe.
Which functions can you map?
Research can cover R&D, clinical, CMC, technical operations, manufacturing, quality, regulatory and device leadership.
How are unresolved contacts handled?
Catch-all, unresolved and non-verifiable outcomes remain separate from the campaign-ready manifest.